July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Protection of cone photoreceptors by CDNF (cerebral dopamine neurotrophic factor)
Author Affiliations & Notes
  • Yiwen Li
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Jianmin Lu
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Yihui Chen
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Rong Wen
    Bascom Palmer Eye Institute, University of Miami, Miami, Florida, United States
  • Footnotes
    Commercial Relationships   Yiwen Li, None; Jianmin Lu, None; Yihui Chen, None; Rong Wen, None
  • Footnotes
    Support  Supported by NIH grants R01EY023666, P30-EY014801, Adrienne Arsht Hope for Vision fund, an unrestricted grant from Research to Prevent Blindness, Inc. , and the National Natural Science Foundation (81300771). RW is the recipient of the 2015 Nelson Trust Award for Retinitis Pigmentosa from Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 999. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yiwen Li, Jianmin Lu, Yihui Chen, Rong Wen; Protection of cone photoreceptors by CDNF (cerebral dopamine neurotrophic factor). Invest. Ophthalmol. Vis. Sci. 2018;59(9):999.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Cerebral dopamine neurotrophic factor (CDNF) is the second member of the MANF family of novel evolutionarily conserved proteins with neurotrophic capabilities. We showed previously that CDNF protects rod photoreceptor from degeneration. The present work examines the neuroprotective effect of CDNF on cone photoreceptors in a transgenic rat model of retinal degeneration, the S334ter-3 rats carrying the rhodopsin S334ter mutation.

Methods : Recombinant human CDNF was expressed in E. coli and purified. At postnatal day (PD) 20, the right eyes of S334ter rat were injected intravitreally with recombinant human CDNF (10 µg in 3 µl PBS), and left eyes were injected with PBS (3 µl) as controls. Eyes were collected at PD 30, and the retina-lens preparations were stained with peanut agglutinin (PNA) to identify cone outer segments. Flat-mounted whole retina were examined by confocal microscopy.

Results : Intravitreal injection of recombinant human CDNF significantly protected cone photoreceptor from degeneration. PNA-positive cells in the superior retina in CDNF treated retinas are 561.5±81.33/0.1 mm2 (mean±SD, n=4), significantly more than those in PBS treated retinas (412.75±40.89/0.1 mm2, n=4) (P < 0.05, Student t-test).

Conclusions : CDNF protects cone from secondary degeneration in S334ter rats.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×